ATE336254T1 - Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten - Google Patents
Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthaltenInfo
- Publication number
- ATE336254T1 ATE336254T1 AT98910670T AT98910670T ATE336254T1 AT E336254 T1 ATE336254 T1 AT E336254T1 AT 98910670 T AT98910670 T AT 98910670T AT 98910670 T AT98910670 T AT 98910670T AT E336254 T1 ATE336254 T1 AT E336254T1
- Authority
- AT
- Austria
- Prior art keywords
- irds
- ards
- treatment
- calcopropylmethoxy
- pyridi
- Prior art date
Links
- 229940066294 lung surfactant Drugs 0.000 title abstract 2
- 239000003580 lung surfactant Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 abstract 2
- 201000000028 adult respiratory distress syndrome Diseases 0.000 abstract 2
- MNDBXUUTURYVHR-UHFFFAOYSA-N roflumilast Chemical compound FC(F)OC1=CC=C(C(=O)NC=2C(=CN=CC=2Cl)Cl)C=C1OCC1CC1 MNDBXUUTURYVHR-UHFFFAOYSA-N 0.000 abstract 2
- 208000032571 Infant acute respiratory distress syndrome Diseases 0.000 abstract 1
- 206010028974 Neonatal respiratory distress syndrome Diseases 0.000 abstract 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 abstract 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 abstract 1
- 201000002652 newborn respiratory distress syndrome Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19705924A DE19705924A1 (de) | 1997-02-17 | 1997-02-17 | Neue Zusammensetzungen |
| EP97102639 | 1997-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE336254T1 true ATE336254T1 (de) | 2006-09-15 |
Family
ID=26033977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98910670T ATE336254T1 (de) | 1997-02-17 | 1998-02-14 | Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US6436970B1 (https=) |
| EP (1) | EP0977577B1 (https=) |
| JP (1) | JP4763104B2 (https=) |
| KR (1) | KR100640025B1 (https=) |
| CN (1) | CN1123345C (https=) |
| AT (1) | ATE336254T1 (https=) |
| AU (1) | AU734122B2 (https=) |
| BR (1) | BR9807399B1 (https=) |
| CA (1) | CA2276429C (https=) |
| CZ (1) | CZ293871B6 (https=) |
| DE (1) | DE69835594T2 (https=) |
| DK (1) | DK0977577T3 (https=) |
| EA (1) | EA001758B1 (https=) |
| EE (1) | EE04094B1 (https=) |
| ES (1) | ES2271990T3 (https=) |
| HU (1) | HU227520B1 (https=) |
| IL (1) | IL130658A (https=) |
| NO (1) | NO323594B1 (https=) |
| NZ (1) | NZ336569A (https=) |
| PL (1) | PL190775B1 (https=) |
| PT (1) | PT977577E (https=) |
| SI (1) | SI0977577T1 (https=) |
| TR (1) | TR199901772T2 (https=) |
| UA (1) | UA50808C2 (https=) |
| WO (1) | WO1998035683A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69835594T2 (de) * | 1997-02-17 | 2007-08-16 | Altana Pharma Ag | Zusammensetzungen zur behandlung von irds oder ards die 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten |
| JP2001081031A (ja) * | 1999-08-30 | 2001-03-27 | Schering Ag | 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤 |
| US7053176B1 (en) | 1999-09-16 | 2006-05-30 | Altana Pharma Ag | Combination of C1-INH and lung surfactant for the treatment of respiratory disorders |
| DE19957898A1 (de) * | 1999-12-01 | 2001-06-07 | Byk Gulden Lomberg Chem Fab | Neue Verwendung von Lungensurfactant |
| AU2001261962B2 (en) * | 2000-05-25 | 2005-04-21 | Merck Frosst Canada Ltd | Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor |
| JP4460221B2 (ja) | 2001-05-24 | 2010-05-12 | メルク フロスト カナダ リミテツド | １−ビアリール−１，８−ナフチリジン−４−オン系ホスホジエステラーゼ−４阻害薬 |
| US20030099601A1 (en) * | 2001-11-27 | 2003-05-29 | Gordon Marc S. | Inhalation lung surfactant therapy |
| US6998384B2 (en) * | 2001-12-12 | 2006-02-14 | The Penn State Research Foundation | Surfactant prevention of lung complications from cancer chemotherapy |
| US20030170223A1 (en) * | 2002-02-01 | 2003-09-11 | Board Of Trustees Of Michigan State University | Pulmonary vasodilator surfactant compositions and method of use |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| US6822114B1 (en) | 2002-10-08 | 2004-11-23 | Albemarle Corporation | Process for production of fluoroalkoxy-substituted benzamides and their intermediates |
| MXPA05005438A (es) * | 2002-11-27 | 2005-08-03 | Altana Pharma Ag | Combinacion sinergica que comprende roflumilast y (r, r) -formoterol. |
| PL216752B1 (pl) * | 2002-11-27 | 2014-05-30 | Nycomed Gmbh | Środek leczniczy do zapobiegania objawom lub do leczenia chorób dróg oddechowych u ludzi i zastosowanie |
| PT1606261E (pt) | 2003-03-10 | 2010-01-11 | Nycomed Gmbh | Novo processo para a preparação de roflumilast |
| ES2383206T3 (es) | 2003-06-16 | 2012-06-19 | Nycomed Gmbh | Composición que comprende un tensioactivo pulmonar y sildenafilo para el tratamiento de neumopatías |
| CA2575513C (en) * | 2004-08-06 | 2014-09-16 | Altana Pharma Ag | Composition comprising a pulmonary surfactant and a tnf-derived peptide |
| US8663694B2 (en) * | 2005-03-16 | 2014-03-04 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| US20100098641A1 (en) * | 2006-12-13 | 2010-04-22 | William Baker | Monophosphates as Mutual Prodrugs of Anti-Inflammatory Signal Transduction Modulators (AISTM's) and Beta-Agonists for the Treatment of Pulmonary Inflammation and Bronchoconstriction |
| WO2009055788A1 (en) * | 2007-10-26 | 2009-04-30 | Aeris Therapeutics, Inc. | Pneumoreductive therapy and compositions useful therein |
| ES2909752T3 (es) * | 2013-08-01 | 2022-05-10 | Swedish Stromabio Ab | MSC en el tratamiento de enfermedades pulmonares inflamatorias |
| CN104800214A (zh) * | 2014-01-27 | 2015-07-29 | 成都英诺新科技有限公司 | 一种罗氟司特吸入气雾剂复方及制备方法 |
| RU2728821C1 (ru) * | 2020-05-13 | 2020-07-31 | Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) | Способ лечения острого респираторного дистресс-синдрома даларгином и легочным сурфактантом |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4223040A (en) * | 1974-11-26 | 1980-09-16 | Carroll John M | Lauric acid for the prevention and treatment of mycobacterial diseases |
| JPS5795920A (en) * | 1980-12-04 | 1982-06-15 | Teijin Ltd | Remedy for respiratory disease |
| JPS5845299A (ja) * | 1981-09-10 | 1983-03-16 | 東京田辺製薬株式会社 | 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤 |
| NZ208107A (en) * | 1983-05-11 | 1986-12-05 | Byk Gulden Lomberg Chem Fab | 6-aryl-3(2h)-pyridazinones and pharmaceutical compositions |
| US4906476A (en) * | 1988-12-14 | 1990-03-06 | Liposome Technology, Inc. | Novel liposome composition for sustained release of steroidal drugs in lungs |
| US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
| ES2176252T3 (es) * | 1993-07-02 | 2002-12-01 | Altana Pharma Ag | Benzamidas sustituidas con fluoro-alcoxi y su utilizacion como agentes inhibidores de fosfodiesterasas de nucleotidos ciclicos. |
| US5856196A (en) * | 1993-10-25 | 1999-01-05 | Beth Israel Hospital | Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor |
| GB9401460D0 (en) | 1994-01-26 | 1994-03-23 | Rhone Poulenc Rorer Ltd | Compositions of matter |
| DE4434629C1 (de) * | 1994-09-28 | 1996-06-27 | Byk Gulden Lomberg Chem Fab | Zusammensetzungen zur Behandlung von IRDS und ARDS |
| US5531219A (en) * | 1994-11-04 | 1996-07-02 | Alliance Pharmaceutical Corp. | Use of liquid fluorocarbons to facilitate pulmonary drug delivery |
| US5698537A (en) * | 1996-06-18 | 1997-12-16 | Clarion Pharmaceuticals Inc. | Method of lowering the viscosity of mucus |
| DE69835594T2 (de) * | 1997-02-17 | 2007-08-16 | Altana Pharma Ag | Zusammensetzungen zur behandlung von irds oder ards die 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten |
| US6180142B1 (en) * | 1998-08-21 | 2001-01-30 | The Regents Of The University Of California | Reduction of surfactant inactivation in pulmonary surfactant therapy |
| JP2003503830A (ja) * | 1999-06-29 | 2003-01-28 | エル−テック コーポレイション | 化学的膜洗浄及び乾燥 |
-
1998
- 1998-02-14 DE DE69835594T patent/DE69835594T2/de not_active Expired - Lifetime
- 1998-02-14 BR BRPI9807399-0A patent/BR9807399B1/pt not_active IP Right Cessation
- 1998-02-14 AT AT98910670T patent/ATE336254T1/de active
- 1998-02-14 EE EEP199900279A patent/EE04094B1/xx unknown
- 1998-02-14 DK DK98910670T patent/DK0977577T3/da active
- 1998-02-14 SI SI9830863T patent/SI0977577T1/sl unknown
- 1998-02-14 AU AU64973/98A patent/AU734122B2/en not_active Expired
- 1998-02-14 EA EA199900645A patent/EA001758B1/ru not_active IP Right Cessation
- 1998-02-14 JP JP53536698A patent/JP4763104B2/ja not_active Expired - Fee Related
- 1998-02-14 UA UA99084669A patent/UA50808C2/uk unknown
- 1998-02-14 CN CN98802597A patent/CN1123345C/zh not_active Expired - Lifetime
- 1998-02-14 ES ES98910670T patent/ES2271990T3/es not_active Expired - Lifetime
- 1998-02-14 PT PT98910670T patent/PT977577E/pt unknown
- 1998-02-14 WO PCT/EP1998/000847 patent/WO1998035683A1/en not_active Ceased
- 1998-02-14 PL PL335134A patent/PL190775B1/pl unknown
- 1998-02-14 EP EP98910670A patent/EP0977577B1/en not_active Expired - Lifetime
- 1998-02-14 KR KR1019997007400A patent/KR100640025B1/ko not_active Expired - Fee Related
- 1998-02-14 CZ CZ19992914A patent/CZ293871B6/cs not_active IP Right Cessation
- 1998-02-14 HU HU0001043A patent/HU227520B1/hu unknown
- 1998-02-14 CA CA002276429A patent/CA2276429C/en not_active Expired - Lifetime
- 1998-02-14 NZ NZ336569A patent/NZ336569A/en not_active IP Right Cessation
- 1998-02-14 IL IL13065898A patent/IL130658A/en not_active IP Right Cessation
- 1998-02-14 TR TR1999/01772T patent/TR199901772T2/xx unknown
-
1999
- 1999-08-06 US US09/369,455 patent/US6436970B1/en not_active Expired - Lifetime
- 1999-08-11 NO NO993875A patent/NO323594B1/no not_active IP Right Cessation
-
2002
- 2002-03-13 US US10/096,258 patent/US6998410B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE336254T1 (de) | Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten | |
| DE60207383D1 (de) | Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen | |
| DE69200675D1 (de) | Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen. | |
| NO20025355L (no) | Farmasöytisk preparat som omfatter en faktor VIIA og en faktor XIII | |
| ATE262895T1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| MY106315A (en) | Pharmaceutical agents | |
| DE69428791D1 (de) | Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden | |
| DE69317494D1 (de) | Zusammensetzungen, die mono oder polyhydroxylierte Aminosäuren zur Behandlung des Insulinunabhängigen Diabetes Mellitus enthalten | |
| ATE297204T1 (de) | Heilmittel für neurodegenerative krankheiten | |
| DE69413829D1 (de) | Antiglucocorticoidsteroide zur behandlung von angststörungen | |
| ATE169225T1 (de) | Anwendung von urodilatin bei lungen- und bronchialerkrankungen | |
| ID28119A (id) | Pati yang dimodifikasi stabil-garam | |
| FR2646603B1 (fr) | Composition nettoyante | |
| DK0944612T3 (da) | N-(4-Acetyl-1-piperazinyl)-4-fluorbenzamidhydrat | |
| ATE190484T1 (de) | Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen | |
| DE60318423D1 (de) | Behandlung des typ 1 diabetes vor und nach expression von prädispositionsmarkern | |
| DE69731620D1 (de) | Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) (1,4)diazepan-1-yl)-2-(aryl)butyl)benzamide zur behandlung von allergischen krankheiten | |
| SE9403861D0 (sv) | Novel medicinal use | |
| PT100508A (pt) | Composicoes farmaceuticas e processo para a sua preparacao | |
| KR880012228A (ko) | 천식 치료제 | |
| MY102682A (en) | Substituted pyridinesulfonamide compounds, herbicidal composition containing them, and method of preparing these compounds | |
| DE50002999D1 (de) | Verwendung von extrakten aus ginkgo-biloba-blättern zur behandlung von schlafstörungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0977577 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |